Cite
HARVARD Citation
Meers, S. et al. (n.d.). Azacitidine access program for Belgian patients with myelodysplastic syndromes, acute myeloid leukemia or chronic myelomonocytic leukemia. Current medical research and opinion. pp. 35-42. [Online].